Loss-of-function mutations or promoter hyper-methylation of MMR genes, such as MSH2 and MLH1, increase susceptibility to cancers, including hereditary non-polyposis colorectal cancer (HNPCC), also called lynch syndrome [1, 2, 4, 8, 9]. This evidence concerns the gene MLH1 and hereditary nonpolyposis colon cancer.